HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 49482,
"recordsTotal": 49482,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=-sponsor__name&start=47100",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=-sponsor__name&start=46500",
"results": [
{
"registry_id": "NCT07689227",
"publication_url": "https://clinicaltrials.gov/study/NCT07689227",
"title": "Early Feasibility Study of the ReWire System for Closed-Loop Vagus Nerve Stimulation (CLV) Paired With Rehabilitation After Spinal Cord Injury (SCI)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas at Dallas",
"sponsor_slug": "the-university-of-texas-at-dallas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06972407",
"publication_url": "https://clinicaltrials.gov/study/NCT06972407",
"title": "The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07683325",
"publication_url": "https://clinicaltrials.gov/study/NCT07683325",
"title": "A Phase 2b, Randomized, Placebo-controlled, Double-blind, Dose-ranging Trial to Assess the Efficacy and Safety of Ontunisertib in Patients With Fibrostenosing Crohn's Disease",
"has_exemption": false,
"start_date": "2026-10-30",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Agomab Spain S.L.U.",
"sponsor_slug": "agomab-spain-slu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04231708",
"publication_url": "https://clinicaltrials.gov/study/NCT04231708",
"title": "Effects of Pharmacological Stress and Repetitive Transcranial Magnetic Stimulation Interventions on Executive Function in Opioid Use Disorder",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wayne State University",
"sponsor_slug": "wayne-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07511556",
"publication_url": "https://clinicaltrials.gov/study/NCT07511556",
"title": "A Phase 1/2, First-in-human, Double-blind, Placebo-controlled Study to Assess Dose, Safety, and Efficacy of UX016 (Sialic Acid-C16 Prodrug) in Adults With GNE Myopathy",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ultragenyx Pharmaceutical Inc",
"sponsor_slug": "ultragenyx-pharmaceutical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07632157",
"publication_url": "https://clinicaltrials.gov/study/NCT07632157",
"title": "MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation (MAGNETIC-AF)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06251609",
"publication_url": "https://clinicaltrials.gov/study/NCT06251609",
"title": "Naloxone for Opioid Associated Out of Hospital Cardiac Arrest",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07106125",
"publication_url": "https://clinicaltrials.gov/study/NCT07106125",
"title": "Trial of Antibiotic Strategies for Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02478450",
"publication_url": "https://clinicaltrials.gov/study/NCT02478450",
"title": "A Phase 1/2a Open-Label Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS): Assessment of Localized Therapeutic Activity by Blinded Observation and Lateral Transplantation (ALTA-BOLT)",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Q Therapeutics, Inc.",
"sponsor_slug": "q-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04003480",
"publication_url": "https://clinicaltrials.gov/study/NCT04003480",
"title": "Prospective, Multicenter Study Evaluating the Performance and Safety of FRAME, External Support for Lower Limb Autologous Grafts.",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vascular Graft Solutions Ltd.",
"sponsor_slug": "vascular-graft-solutions-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04441008",
"publication_url": "https://clinicaltrials.gov/study/NCT04441008",
"title": "Radical aiTBS Protocol for Intractable Depression",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Iowa",
"sponsor_slug": "university-of-iowa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06180616",
"publication_url": "https://clinicaltrials.gov/study/NCT06180616",
"title": "Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity: A Placebo-Matched Randomised Controlled Trial",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Royal North Shore Hospital",
"sponsor_slug": "royal-north-shore-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06553651",
"publication_url": "https://clinicaltrials.gov/study/NCT06553651",
"title": "Necrosectomy With Cryotechnology for Accelerated Removal",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Christopher C. Thompson, MD, MSc",
"sponsor_slug": "christopher-c-thompson-md-msc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07125183",
"publication_url": "https://clinicaltrials.gov/study/NCT07125183",
"title": "A Phase II Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma of Soft Tissue",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02944955",
"publication_url": "https://clinicaltrials.gov/study/NCT02944955",
"title": "A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BioLite, Inc.",
"sponsor_slug": "biolite-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06064604",
"publication_url": "https://clinicaltrials.gov/study/NCT06064604",
"title": "Clinical Trial: Powered Hip & Ankle Exoskeletons for Stroke Survivors With Gait Impairment",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Georgia Institute of Technology",
"sponsor_slug": "georgia-institute-of-technology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06704100",
"publication_url": "https://clinicaltrials.gov/study/NCT06704100",
"title": "A Phase 2, Randomized, Double-blind, Placebo-controlled Trial of Fosamprenavir-Sodium Alginate Administered Orally for 8 Weeks to Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06899958",
"publication_url": "https://clinicaltrials.gov/study/NCT06899958",
"title": "Metabolism Enhancement by Laser Therapy",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07566104",
"publication_url": "https://clinicaltrials.gov/study/NCT07566104",
"title": "Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2028-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00018057",
"publication_url": "https://clinicaltrials.gov/study/NCT00018057",
"title": "Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders",
"has_exemption": false,
"start_date": "2001-10-02",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Mental Health (NIMH)",
"sponsor_slug": "national-institute-of-mental-health-nimh",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02830724",
"publication_url": "https://clinicaltrials.gov/study/NCT02830724",
"title": "A Phase I/II Study Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to Patients With CD70-Expressing Cancers",
"has_exemption": false,
"start_date": "2017-04-06",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03202940",
"publication_url": "https://clinicaltrials.gov/study/NCT03202940",
"title": "A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC",
"has_exemption": false,
"start_date": "2017-09-14",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06203756",
"publication_url": "https://clinicaltrials.gov/study/NCT06203756",
"title": "Improved Patient Outcomes With Robotic-Assisted Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2017-11-09",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Corin",
"sponsor_slug": "corin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03583710",
"publication_url": "https://clinicaltrials.gov/study/NCT03583710",
"title": "A Randomized Registry Trial of Adjuvant Mitotane vs. Mitotane With Cisplatin/Etoposide After Primary Surgical Resection of Localized Adrenocortical Carcinoma With High Risk of Recurrence (ADIUVO-2 Trial)",
"has_exemption": false,
"start_date": "2018-08-20",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04116996",
"publication_url": "https://clinicaltrials.gov/study/NCT04116996",
"title": "Stimulation of the External Pallidal Segment for Insomnia in Patients With Parkinson's Disease",
"has_exemption": false,
"start_date": "2019-01-01",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04197765",
"publication_url": "https://clinicaltrials.gov/study/NCT04197765",
"title": "Accelerated Continuous Theta-burst Stimulation (acTBS) for Suicidal Ideation in the Psychiatric Inpatient Setting: A Pilot Study",
"has_exemption": false,
"start_date": "2020-01-01",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04803318",
"publication_url": "https://clinicaltrials.gov/study/NCT04803318",
"title": "Trametinib Combined With Everolimus and Lenvatinib in the Treatment of Recurrent/Refractory Advanced Solid Tumors: a Phase II Clinical Trial",
"has_exemption": false,
"start_date": "2021-01-01",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04772079",
"publication_url": "https://clinicaltrials.gov/study/NCT04772079",
"title": "A Multicenter, Randomized, Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Deucravacitinib (BMS-986165) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis",
"has_exemption": false,
"start_date": "2021-03-23",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06004336",
"publication_url": "https://clinicaltrials.gov/study/NCT06004336",
"title": "A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)",
"has_exemption": false,
"start_date": "2023-10-31",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06031259",
"publication_url": "https://clinicaltrials.gov/study/NCT06031259",
"title": "An Open-Label Extension for Subjects in Studies HGT-HIT-046 and SHP609-302 Evaluating Long-Term Safety of Intrathecal Idursulfase-IT Administered in Conjunction With Intravenous Elaprase® in Subjects With Hunter Syndrome and Cognitive Impairment",
"has_exemption": false,
"start_date": "2024-03-05",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06122675",
"publication_url": "https://clinicaltrials.gov/study/NCT06122675",
"title": "Cerebellar Deep Brain Stimulation for Severe Combined Movement Disorders and Spasticity in Children and Young Adults With Cerebral Palsy",
"has_exemption": false,
"start_date": "2024-03-26",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06134362",
"publication_url": "https://clinicaltrials.gov/study/NCT06134362",
"title": "A Phase IIIB, Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition",
"has_exemption": false,
"start_date": "2024-05-14",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ViiV Healthcare",
"sponsor_slug": "viiv-healthcare",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06264180",
"publication_url": "https://clinicaltrials.gov/study/NCT06264180",
"title": "Randomized, Ph3 Clinical Study Comparing Vusolimogene Oderparepvec in Combination With Nivolumab Vs Treatment of Physician's Choice in Patients With Advanced Melanoma That Progressed on Anti-PD-1 and Anti-CTLA-4 Containing Treatment [IGNYTE-3]",
"has_exemption": false,
"start_date": "2024-07-11",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Replimune Inc.",
"sponsor_slug": "replimune-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06402955",
"publication_url": "https://clinicaltrials.gov/study/NCT06402955",
"title": "Identifying the Neural Basis of Depression in Parkinson's Disease",
"has_exemption": false,
"start_date": "2024-09-01",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06468202",
"publication_url": "https://clinicaltrials.gov/study/NCT06468202",
"title": "Comparative Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL",
"has_exemption": false,
"start_date": "2024-10-18",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04736953",
"publication_url": "https://clinicaltrials.gov/study/NCT04736953",
"title": "Sirolimus Treatment of Patients With Systemic Lupus Erythematosus",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "State University of New York - Upstate Medical University",
"sponsor_slug": "state-university-of-new-york-upstate-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187063",
"publication_url": "https://clinicaltrials.gov/study/NCT07187063",
"title": "Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Lahey Clinic",
"sponsor_slug": "lahey-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07195903",
"publication_url": "https://clinicaltrials.gov/study/NCT07195903",
"title": "Evaluation of Supracardiac Venous Angioplasty and Stenting on Ortho- Static Intolerance and Orthostatic Hypotension - The STANDUP Study",
"has_exemption": false,
"start_date": "2025-01-23",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Francis Hospital, New York",
"sponsor_slug": "st-francis-hospital-new-york",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06310213",
"publication_url": "https://clinicaltrials.gov/study/NCT06310213",
"title": "Non-Invasive Pressure Monitor for Neonates & Infants at Risk of Developing Hydrocephalus",
"has_exemption": false,
"start_date": "2025-01-24",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06757140",
"publication_url": "https://clinicaltrials.gov/study/NCT06757140",
"title": "Opioid Drug Interactions: Safety, Abuse Potential and Pharmacokinetic Effects",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanna Babalonis, PhD",
"sponsor_slug": "shanna-babalonis-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06733012",
"publication_url": "https://clinicaltrials.gov/study/NCT06733012",
"title": "Splanchnic Nerve Modulation In Heart Failure (Splanchnic X)",
"has_exemption": false,
"start_date": "2025-04-05",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06595459",
"publication_url": "https://clinicaltrials.gov/study/NCT06595459",
"title": "A Randomized Comparative Effectiveness Trial of Nicotine Pouches for Cigarette Substitution: A Question of Public Health",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06966128",
"publication_url": "https://clinicaltrials.gov/study/NCT06966128",
"title": "The Effect of Transcranial Direct Current Stimulation on Cerebral Blood Flow in Patients With Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Universitair Ziekenhuis Brussel",
"sponsor_slug": "universitair-ziekenhuis-brussel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06306443",
"publication_url": "https://clinicaltrials.gov/study/NCT06306443",
"title": "A Comparative Effectiveness Trial of Sublingual Versus Extended-release Buprenorphine With Individuals Leaving a Carceral Setting",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Friends Research Institute, Inc.",
"sponsor_slug": "friends-research-institute-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07140484",
"publication_url": "https://clinicaltrials.gov/study/NCT07140484",
"title": "A Single-arm, Open-label Phase IV Study to Evaluate the Effectiveness of Sotatercept in Improving Pulmonary Vascular Recruitment in Patients With Pulmonary Arterial Hypertension (PAH)",
"has_exemption": false,
"start_date": "2025-10-06",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alberta",
"sponsor_slug": "university-of-alberta",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06627673",
"publication_url": "https://clinicaltrials.gov/study/NCT06627673",
"title": "MultiCenter Prospective Parallel Registry Controlled Investigational Device Exemption Clinical Study to Determine Non-Inferiority of the PEEK-OPTIMA™ Femoral Component Versus a CoCr Alloy Femoral Component of Similar Design for TKA",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Maxx Orthopedics Inc",
"sponsor_slug": "maxx-orthopedics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325721",
"publication_url": "https://clinicaltrials.gov/study/NCT07325721",
"title": "Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer",
"has_exemption": false,
"start_date": "2026-02-02",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06691217",
"publication_url": "https://clinicaltrials.gov/study/NCT06691217",
"title": "Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis",
"has_exemption": false,
"start_date": "2026-03-24",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07433023",
"publication_url": "https://clinicaltrials.gov/study/NCT07433023",
"title": "Advancing Neurorehabilitation: Evaluating Transcutaneous Spinal Stimulation and 5-Azacitidine for Enhanced Motor Outcomes in Cerebral Palsy",
"has_exemption": false,
"start_date": "2026-05-28",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shirley Ryan AbilityLab",
"sponsor_slug": "shirley-ryan-abilitylab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07294131",
"publication_url": "https://clinicaltrials.gov/study/NCT07294131",
"title": "Targeting Muscle Strength Loss Due to Hospitalization in Older Adults by Blood-flow Restriction Combined With an EMG-driven Serious Game",
"has_exemption": false,
"start_date": "2026-06-05",
"completion_date": "2029-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vrije Universiteit Brussel",
"sponsor_slug": "vrije-universiteit-brussel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06109779",
"publication_url": "https://clinicaltrials.gov/study/NCT06109779",
"title": "A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Rilvegostomig in Combination With Chemotherapy as Adjuvant Treatment After Resection of Biliary Tract Cancer With Curative Intent (ARTEMIDE-Biliary01)",
"has_exemption": false,
"start_date": "2023-12-04",
"completion_date": "2029-01-02",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06691984",
"publication_url": "https://clinicaltrials.gov/study/NCT06691984",
"title": "A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Subjects With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Chemotherapy",
"has_exemption": false,
"start_date": "2024-12-09",
"completion_date": "2029-01-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06760637",
"publication_url": "https://clinicaltrials.gov/study/NCT06760637",
"title": "AN INTERVENTIONAL, OPEN-LABEL, RANDOMIZED, MULTICENTER PHASE 3 STUDY OF PF-07220060 PLUS LETROZOLE COMPARED TO CDK4/6 INHIBITOR PLUS LETROZOLE IN PARTICIPANTS OVER 18 YEARS OF AGE WITH HORMONE RECEPTOR (HR)-POSITIVE, HER2-NEGATIVE ADVANCED/METASTATIC BREAST CANCER WHO HAVE NOT RECEIVED ANY PRIOR SYSTEMIC ANTICANCER TREATMENT FOR ADVANCED/METASTATIC DISEASE (FOURLIGHT-3)",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2029-01-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06257706",
"publication_url": "https://clinicaltrials.gov/study/NCT06257706",
"title": "An Interventional Study to Evaluate Treating to a Target of Transmural Healing in Patients With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2029-01-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Alimentiv Inc.",
"sponsor_slug": "alimentiv-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04728893",
"publication_url": "https://clinicaltrials.gov/study/NCT04728893",
"title": "A Phase 2 Study to Evaluate the Efficacy and Safety of MK-1026 in Participants With Hematologic Malignancies",
"has_exemption": false,
"start_date": "2021-04-05",
"completion_date": "2029-01-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06697197",
"publication_url": "https://clinicaltrials.gov/study/NCT06697197",
"title": "A Phase 1/2 Study of BMS-986482 as Monotherapy or Combination Therapy in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2029-01-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07005128",
"publication_url": "https://clinicaltrials.gov/study/NCT07005128",
"title": "A Phase 3, Open Label, Multicenter, Randomized Study of First Line Tarlatamab in Combination With Durvalumab, Carboplatin and Etoposide Versus Durvalumab, Carboplatin and Etoposide in Untreated Extensive Stage Small-Cell Lung Cancer (DeLLphi-312)",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2029-01-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07323732",
"publication_url": "https://clinicaltrials.gov/study/NCT07323732",
"title": "A Phase II Study of BIO 300 to Reduce the Toxicity of Thoracic Radiotherapy for Patients With Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease (BREATHE)",
"has_exemption": false,
"start_date": "2026-01-06",
"completion_date": "2029-01-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06033196",
"publication_url": "https://clinicaltrials.gov/study/NCT06033196",
"title": "Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Tocilizumab (CTOT-45)",
"has_exemption": false,
"start_date": "2024-02-13",
"completion_date": "2029-01-08",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06324357",
"publication_url": "https://clinicaltrials.gov/study/NCT06324357",
"title": "Beamion BCGC-1: A Phase Ib Dose Escalation and Phase II Dose Optimization, Randomized, Open-label, Multicenter Trial of Oral Zongertinib (BI 1810631) Alone or in Combination With Other Agents for the Treatment of Patients With Advanced HER2+ Metastatic Breast Cancer (mBC), Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (mGEAC), or Metastatic Colorectal Cancer (mCRC)",
"has_exemption": false,
"start_date": "2024-06-03",
"completion_date": "2029-01-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06735248",
"publication_url": "https://clinicaltrials.gov/study/NCT06735248",
"title": "A Phase 2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study of mRNA-1195 Intramuscular Injection in Participants 18 to ≤55 Years of Age With Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-04-16",
"completion_date": "2029-01-08",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04649242",
"publication_url": "https://clinicaltrials.gov/study/NCT04649242",
"title": "Phase 3, Multicenter, Randomized, Double-blind, Group Sequential, Placebo-controlled Study to Assess Efficacy and Safety of Rimegepant for the Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to < 18 Years of Age",
"has_exemption": false,
"start_date": "2021-01-15",
"completion_date": "2029-01-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05672355",
"publication_url": "https://clinicaltrials.gov/study/NCT05672355",
"title": "Randomized Observer-Blinded Phase 2 Trial of COVID-19 Booster With GEO-CM04S1 or mRNA Vaccine in Patients With Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2023-08-01",
"completion_date": "2029-01-12",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06422143",
"publication_url": "https://clinicaltrials.gov/study/NCT06422143",
"title": "Phase 3 Study of Pembrolizumab in Combination With Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab With or Without Maintenance MK-2870 in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-06-10",
"completion_date": "2029-01-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06353386",
"publication_url": "https://clinicaltrials.gov/study/NCT06353386",
"title": "MK-5684-01A Substudy: A Phase 1/2 Umbrella Substudy of MK-5684-U01 Master Protocol to Evaluate the Safety and Efficacy of MK-5684-based Treatment Combinations or MK-5684 Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2024-05-20",
"completion_date": "2029-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06733350",
"publication_url": "https://clinicaltrials.gov/study/NCT06733350",
"title": "Investigating the Effect of Testosterone Replacement Therapy Among Hypogonadal Men With Localized Prostate Cancer on Active Surveillance",
"has_exemption": false,
"start_date": "2025-01-15",
"completion_date": "2029-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07397169",
"publication_url": "https://clinicaltrials.gov/study/NCT07397169",
"title": "Adjustable Sockets for Veterans With Lower Limb Amputation: Patient Reported Outcomes and Within-socket Pressures",
"has_exemption": false,
"start_date": "2026-06-15",
"completion_date": "2029-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07683975",
"publication_url": "https://clinicaltrials.gov/study/NCT07683975",
"title": "Infliximab for Immune Checkpoint Inhibitor Associated Acute Kidney Injury: A Pilot Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2026-07-16",
"completion_date": "2029-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07613359",
"publication_url": "https://clinicaltrials.gov/study/NCT07613359",
"title": "A Double-Blind, Placebo-Controlled, Multicenter, Randomized, Phase 2 Trial to Evaluate the Safety and Efficacy of Mezagitamab (TAK-079) in Kidney Transplant Recipients With Late Antibody-Mediated Rejection (AMR)",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07610525",
"publication_url": "https://clinicaltrials.gov/study/NCT07610525",
"title": "Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Tria",
"has_exemption": false,
"start_date": "2026-11-05",
"completion_date": "2029-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07356154",
"publication_url": "https://clinicaltrials.gov/study/NCT07356154",
"title": "A Phase 1/2 Study of the Menin Inhibitor Revumenib With the CELMod Mezigdomide in Relapsed/Refractory KMT2A-rearanged, NPM1-mutant, and NUP98-rearranged Acute Leukemias",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2029-01-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05677971",
"publication_url": "https://clinicaltrials.gov/study/NCT05677971",
"title": "A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease With METAVIR Stage F2 to F4 Fibrosis",
"has_exemption": false,
"start_date": "2023-03-06",
"completion_date": "2029-01-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07181161",
"publication_url": "https://clinicaltrials.gov/study/NCT07181161",
"title": "A Modular Phase I/IIa, Open-label, Multi-centre Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of AZD0516 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Metastatic Prostate Cancer",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2029-01-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06989112",
"publication_url": "https://clinicaltrials.gov/study/NCT06989112",
"title": "DESTINY-Endometrial01: An Open-Label, Sponsor-Blinded, Randomized, Controlled, Multicenter, Phase III Study of Trastuzumab Deruxtecan (T-DXd) Plus Rilvegostomig or Pembrolizumab vs Chemotherapy Plus Pembrolizumab as First-Line Therapy of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR), Primary Advanced or Recurrent Endometrial Cancer",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2029-01-19",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05492578",
"publication_url": "https://clinicaltrials.gov/study/NCT05492578",
"title": "A Long-term Extension Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Subcutaneous Amlitelimab in Participants of Previous Amlitelimab Clinical Trials in Moderate to Severe Atopic Dermatitis.",
"has_exemption": false,
"start_date": "2022-08-22",
"completion_date": "2029-01-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06149286",
"publication_url": "https://clinicaltrials.gov/study/NCT06149286",
"title": "A Phase 3, Open Label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Combination With Lenalidomide Versus Rituximab in Combination With Lenalidomide in Relapsed/Refractory Participants With Follicular Lymphoma and Marginal Zone Lymphoma (OLYMPIA-5)",
"has_exemption": false,
"start_date": "2023-12-28",
"completion_date": "2029-01-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07042438",
"publication_url": "https://clinicaltrials.gov/study/NCT07042438",
"title": "A Phase 2 Randomized Trial of Remodeling Intestinal Microbiota Using Fecal Microbiome Transplant (FMT) Among Recipients of Chimeric Antigen Receptor T Cells (CAR T)",
"has_exemption": false,
"start_date": "2026-02-11",
"completion_date": "2029-01-23",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07493577",
"publication_url": "https://clinicaltrials.gov/study/NCT07493577",
"title": "Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2",
"has_exemption": false,
"start_date": "2026-07-23",
"completion_date": "2029-01-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Dr David Hasan, M.D.",
"sponsor_slug": "dr-david-hasan-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04954859",
"publication_url": "https://clinicaltrials.gov/study/NCT04954859",
"title": "A Prospective, Multi-Centre Study (B-Sure) to Evaluate Long-Term Durability of Treatment Response in Chronic Hepatitis B Participants With and Without Nucleos(t)Ide Therapy Who Have Participated in a Previous Bepirovirsen Treatment Study",
"has_exemption": false,
"start_date": "2021-12-14",
"completion_date": "2029-01-24",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05734495",
"publication_url": "https://clinicaltrials.gov/study/NCT05734495",
"title": "A Phase II Study Evaluating Venetoclax and Pirtobrutinib in Previously Treated Waldenström Macroglobulinemia",
"has_exemption": false,
"start_date": "2023-05-02",
"completion_date": "2029-01-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07106762",
"publication_url": "https://clinicaltrials.gov/study/NCT07106762",
"title": "IZABRIGHT-Bladder01: A Randomized, Open-label, Phase 2/3 Trial of Izalontamab Brengitecan Versus Platinum-based Chemotherapy for Metastatic Urothelial Cancer in Participants With Disease Progression on or After an Immunotherapy-based Treatment",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-01-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07336446",
"publication_url": "https://clinicaltrials.gov/study/NCT07336446",
"title": "A Phase I/II, Modular, Open-Label, Multi-Centre Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of AZD9750 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Metastatic Prostate Cancer (ANDROMEDA)",
"has_exemption": false,
"start_date": "2026-01-27",
"completion_date": "2029-01-26",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07430306",
"publication_url": "https://clinicaltrials.gov/study/NCT07430306",
"title": "Multinational, Interventional, 52-week, Open-label, Single-arm Study to Evaluate the Treatment Outcomes of Anifrolumab 120 mg Subcutaneous Once Weekly in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus (SUNFLOWER)",
"has_exemption": false,
"start_date": "2026-04-13",
"completion_date": "2029-01-26",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03851445",
"publication_url": "https://clinicaltrials.gov/study/NCT03851445",
"title": "LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)",
"has_exemption": false,
"start_date": "2019-02-06",
"completion_date": "2029-01-28",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227948",
"publication_url": "https://clinicaltrials.gov/study/NCT07227948",
"title": "Repurposing Semaglutide for the Treatment of Cocaine Use Disorder: a Pilot Mechanistic Study",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2029-01-28",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06082037",
"publication_url": "https://clinicaltrials.gov/study/NCT06082037",
"title": "A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study, Followed by Open-label Extensions, to Evaluate the Efficacy of Oral Belumosudil in Adult Participants With Chronic Lung Allograft Dysfunction (CLAD) Following Bilateral Lung Transplantation",
"has_exemption": false,
"start_date": "2023-10-10",
"completion_date": "2029-01-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07291037",
"publication_url": "https://clinicaltrials.gov/study/NCT07291037",
"title": "A Phase III, Randomised, Open-Label, Multicentre Study of Datopotamab Deruxtecan or Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung17)",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2029-01-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926621",
"publication_url": "https://clinicaltrials.gov/study/NCT06926621",
"title": "An Open-label Extension Study Evaluating the Long-term Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-670 in Adult Subjects With Myotonic Dystrophy Type I",
"has_exemption": false,
"start_date": "2025-04-28",
"completion_date": "2029-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07116109",
"publication_url": "https://clinicaltrials.gov/study/NCT07116109",
"title": "Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced, Entirely Remote 2-Week Integrated Treatment for Pain and PTSD",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2029-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07686380",
"publication_url": "https://clinicaltrials.gov/study/NCT07686380",
"title": "Phase II Trial of IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy",
"has_exemption": false,
"start_date": "2026-07-15",
"completion_date": "2029-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01984710",
"publication_url": "https://clinicaltrials.gov/study/NCT01984710",
"title": "Deep Brain Stimulation for Treatment Resistant Depression: Exploration of Local Field Potentials (LFP) With the Medtronic Activa Primary Cell + Sensing (PC+S) \"Brain Radio\" System",
"has_exemption": false,
"start_date": "2013-09-30",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02724371",
"publication_url": "https://clinicaltrials.gov/study/NCT02724371",
"title": "Post-Approval Study of the Safety and Effectiveness of the Mentor Smooth Larger Size MemoryGel Ultra High Profile (UHP-L) Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction",
"has_exemption": false,
"start_date": "2016-04-01",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mentor Worldwide, LLC",
"sponsor_slug": "mentor-worldwide-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03001830",
"publication_url": "https://clinicaltrials.gov/study/NCT03001830",
"title": "GO-8: Gene Therapy for Haemophilia A Using a Novel Serotype 8 Capsid Pseudotyped Adeno-associated Viral Vector Encoding Factor VIII-V3",
"has_exemption": false,
"start_date": "2017-06-14",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University College, London",
"sponsor_slug": "university-college-london",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03271372",
"publication_url": "https://clinicaltrials.gov/study/NCT03271372",
"title": "A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial of Adjuvant Avelumab (Anti-PDL-1 Antibody) in Merkel Cell Carcinoma Patients With Lymph Node Metastases",
"has_exemption": false,
"start_date": "2017-12-19",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03625037",
"publication_url": "https://clinicaltrials.gov/study/NCT03625037",
"title": "A Phase 1/2, Open-label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma",
"has_exemption": false,
"start_date": "2018-06-26",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03661645",
"publication_url": "https://clinicaltrials.gov/study/NCT03661645",
"title": "Post-operative Methylprednisolone Taper Course for Orthopedic Surgery",
"has_exemption": false,
"start_date": "2018-09-07",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03633708",
"publication_url": "https://clinicaltrials.gov/study/NCT03633708",
"title": "Phase 3, Randomized, Open-label, Controlled, Multiple Dose, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Etelcalcetide in Pediatric Subjects 28 Days to < 18 Years of Age With Secondary Hyperparathyroidism and Chronic Kidney Disease Receiving Maintenance Hemodialysis",
"has_exemption": false,
"start_date": "2019-04-29",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03649880",
"publication_url": "https://clinicaltrials.gov/study/NCT03649880",
"title": "Feasibility of [¹⁸F]-Fluoromisonidazole (FMISO) in Assessment of Malignant Brain Tumors",
"has_exemption": false,
"start_date": "2019-06-01",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04226547",
"publication_url": "https://clinicaltrials.gov/study/NCT04226547",
"title": "Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants",
"has_exemption": false,
"start_date": "2020-07-07",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04422912",
"publication_url": "https://clinicaltrials.gov/study/NCT04422912",
"title": "A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris",
"has_exemption": false,
"start_date": "2020-09-29",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05098132",
"publication_url": "https://clinicaltrials.gov/study/NCT05098132",
"title": "A Phase 1/2 Study to Evaluate STK-012 as a Single Agent and in Combination Therapy in Subjects With Front-line Advanced NSCLC and Other Selected Indications",
"has_exemption": false,
"start_date": "2022-01-25",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Synthekine",
"sponsor_slug": "synthekine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05746143",
"publication_url": "https://clinicaltrials.gov/study/NCT05746143",
"title": "The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion: A Randomized Control Trial",
"has_exemption": false,
"start_date": "2022-02-01",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04354077",
"publication_url": "https://clinicaltrials.gov/study/NCT04354077",
"title": "Pilot Study to Evaluate Deep Brain Stimulation (DBS) of the Nucleus Accumbens (NAc) for Patients With Treatment-refractory Opioid Use Disorder",
"has_exemption": false,
"start_date": "2022-02-07",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)",
"sponsor_slug": "allegheny-singer-research-institute-also-known-as-allegheny-health-network-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05438043",
"publication_url": "https://clinicaltrials.gov/study/NCT05438043",
"title": "A Phase 3b, Multicenter, Open-label, Daratumumab Long-term Extension Study",
"has_exemption": false,
"start_date": "2022-12-15",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05887609",
"publication_url": "https://clinicaltrials.gov/study/NCT05887609",
"title": "A Phase II Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine-gynx and Olaparib in Recurrent Platinum Sensitive Ovarian, Peritoneal, and Fallopian Tube Cancer",
"has_exemption": false,
"start_date": "2023-10-03",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06211348",
"publication_url": "https://clinicaltrials.gov/study/NCT06211348",
"title": "Genomic Sequencing in Anatomically Normal Fetuses",
"has_exemption": false,
"start_date": "2024-01-01",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06098079",
"publication_url": "https://clinicaltrials.gov/study/NCT06098079",
"title": "A Phase IV Study to Assess the Effect of Naltrexone Hydrochloride Extended Release (ER) and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on the Occurrence of Major Adverse Cardiovascular Events",
"has_exemption": false,
"start_date": "2024-01-03",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Currax Pharmaceuticals",
"sponsor_slug": "currax-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06169397",
"publication_url": "https://clinicaltrials.gov/study/NCT06169397",
"title": "A Long-term Multicenter Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement",
"has_exemption": false,
"start_date": "2024-03-01",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Xentria, Inc.",
"sponsor_slug": "xentria-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06234631",
"publication_url": "https://clinicaltrials.gov/study/NCT06234631",
"title": "Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty - a Randomized, Two by Two Factorial, Double-blind, Placebo-controlled Clinical Trial",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Chad Brummett",
"sponsor_slug": "chad-brummett",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06397469",
"publication_url": "https://clinicaltrials.gov/study/NCT06397469",
"title": "Optimizing a Closed-loop Digital Meditation Intervention for Remediating Cognitive Decline and Reducing Stress in Older Adults",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06045767",
"publication_url": "https://clinicaltrials.gov/study/NCT06045767",
"title": "T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer",
"has_exemption": false,
"start_date": "2024-06-30",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ari Raphael",
"sponsor_slug": "ari-raphael",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06592599",
"publication_url": "https://clinicaltrials.gov/study/NCT06592599",
"title": "A Safety, Feasibility and Efficacy Study of Gemcitabine Plus Docetaxel Plus Toripalimab (GDT) Induction as Part of a Curative Sequential Chemoradiation for Patients With Locoregional EBV Associated Nasopharyngeal Carcinoma (NPC)",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06450886",
"publication_url": "https://clinicaltrials.gov/study/NCT06450886",
"title": "An Open-label, Multicenter Study to Evaluate the Long-term Safety and Efficacy of Ulviprubart (ABC008) in Subjects Who Have Completed a Trial of Ulviprubart for the Treatment of Inclusion Body Myositis",
"has_exemption": false,
"start_date": "2024-10-21",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Abcuro, Inc.",
"sponsor_slug": "abcuro-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06672458",
"publication_url": "https://clinicaltrials.gov/study/NCT06672458",
"title": "Upper Extremity Functional Electrical Stimulation (FES) for Restoration of Upper Extremity Function After Spinal Cord Injury (SCI)",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06477146",
"publication_url": "https://clinicaltrials.gov/study/NCT06477146",
"title": "Pilot Study of Milk Thistle for the Treatment of Pediatric Non-Alcoholic Fatty Liver Disease (NAFLD)",
"has_exemption": false,
"start_date": "2024-12-19",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospitals Cleveland Medical Center",
"sponsor_slug": "university-hospitals-cleveland-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06706076",
"publication_url": "https://clinicaltrials.gov/study/NCT06706076",
"title": "A Phase 1/2 Open-Label, Multicenter, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of BH-30643 in Adult Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations (SOLARA)",
"has_exemption": false,
"start_date": "2025-01-09",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BlossomHill Therapeutics",
"sponsor_slug": "blossomhill-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06734130",
"publication_url": "https://clinicaltrials.gov/study/NCT06734130",
"title": "A Phase IIA Study of Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer",
"has_exemption": false,
"start_date": "2025-01-10",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05971758",
"publication_url": "https://clinicaltrials.gov/study/NCT05971758",
"title": "Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease",
"has_exemption": false,
"start_date": "2025-01-16",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06289985",
"publication_url": "https://clinicaltrials.gov/study/NCT06289985",
"title": "STEP: StrokeNet Thrombectomy Endovascular Platform",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847321",
"publication_url": "https://clinicaltrials.gov/study/NCT06847321",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Lighthouse Pharmaceuticals, Inc.",
"sponsor_slug": "lighthouse-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679374",
"publication_url": "https://clinicaltrials.gov/study/NCT06679374",
"title": "Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease",
"has_exemption": false,
"start_date": "2025-04-09",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vikas Kotagal",
"sponsor_slug": "vikas-kotagal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227246",
"publication_url": "https://clinicaltrials.gov/study/NCT07227246",
"title": "Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial - Part 2",
"has_exemption": false,
"start_date": "2025-05-06",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Joseph Broderick, MD",
"sponsor_slug": "joseph-broderick-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06588699",
"publication_url": "https://clinicaltrials.gov/study/NCT06588699",
"title": "Clinical Trial of Oral Digoxin In NASH (CODIN)",
"has_exemption": false,
"start_date": "2025-06-05",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06905522",
"publication_url": "https://clinicaltrials.gov/study/NCT06905522",
"title": "A Pan-Ultrashort Regimen for Drug-susceptible and Drug-resistant Pulmonary Tuberculosis: A Multi-Center Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-06-18",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shenzhen Third People's Hospital",
"sponsor_slug": "shenzhen-third-peoples-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06995898",
"publication_url": "https://clinicaltrials.gov/study/NCT06995898",
"title": "The Vanguard Study: Testing a New Way to Screen for Cancer",
"has_exemption": false,
"start_date": "2025-06-18",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06872684",
"publication_url": "https://clinicaltrials.gov/study/NCT06872684",
"title": "Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Neurovascular",
"sponsor_slug": "stryker-neurovascular",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07111520",
"publication_url": "https://clinicaltrials.gov/study/NCT07111520",
"title": "A Phase Ib/II, Multi-site, Open-label, Dose Finding Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of BNT326 in Combination With BNT327 in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07573540",
"publication_url": "https://clinicaltrials.gov/study/NCT07573540",
"title": "Optimizing Algorithmic Feedback About Lapse Risk for Trust, Engagement, and Clinical Outcomes for Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-09-24",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06927024",
"publication_url": "https://clinicaltrials.gov/study/NCT06927024",
"title": "A Randomized, Sham-controlled Pilot Trial of a Novel Therapeutic Strategy (taVNS) for Autonomic Nervous System (ANS) Dysfunction in Chronic Kidney Disease (CKD)",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07160634",
"publication_url": "https://clinicaltrials.gov/study/NCT07160634",
"title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy of a Single Intravenous Dose of SGT-003 in Ambulant Males With Duchenne Muscular Dystrophy",
"has_exemption": false,
"start_date": "2025-10-22",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Solid Biosciences Inc.",
"sponsor_slug": "solid-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06626503",
"publication_url": "https://clinicaltrials.gov/study/NCT06626503",
"title": "Prospective Randomized Evaluation of Analgesia for Spine Fusion Elective Surgery in Children (PRECISE Spine Trial)",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Senthil Sadhasivam",
"sponsor_slug": "senthil-sadhasivam",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07059845",
"publication_url": "https://clinicaltrials.gov/study/NCT07059845",
"title": "A Phase 2, Open-Label, Randomized, Master Protocol Dose Optimization Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations With Mirvetuximab Soravtansine in Subjects With Ovarian Cancer",
"has_exemption": false,
"start_date": "2025-11-13",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06626035",
"publication_url": "https://clinicaltrials.gov/study/NCT06626035",
"title": "Prospective Randomized Evaluation of Analgesia for Cardiac Elective Surgery in Children (PRECISE Cardiac Trial)",
"has_exemption": false,
"start_date": "2025-12-17",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Senthil Sadhasivam",
"sponsor_slug": "senthil-sadhasivam",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220603",
"publication_url": "https://clinicaltrials.gov/study/NCT07220603",
"title": "An Open-Label Extension Study Evaluating Safety and Pharmacokinetics in Participants With Myotonic Dystrophy Type 1 (FREEDOM-OLE)",
"has_exemption": false,
"start_date": "2025-12-23",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "PepGen Inc",
"sponsor_slug": "pepgen-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07359846",
"publication_url": "https://clinicaltrials.gov/study/NCT07359846",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma",
"has_exemption": false,
"start_date": "2026-01-20",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Generate Biomedicines",
"sponsor_slug": "generate-biomedicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07359859",
"publication_url": "https://clinicaltrials.gov/study/NCT07359859",
"title": "Randomized Pilot Study of Ruxolitinib for Switch-Maintenance Prophylaxis of Graft-versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation After Intermediate-Dose Post-Transplant Cyclophosphamide (Rux Switch-Maintenance in Intermediate PTCY: RuSMa-PTCY) in Comparison to Full-Dose PTCY",
"has_exemption": false,
"start_date": "2026-01-20",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07326657",
"publication_url": "https://clinicaltrials.gov/study/NCT07326657",
"title": "Open-label, Controlled, Randomized, Multicenter Study Evaluating Intact Fish Skin Graft in Promoting AutoLOgous Skin Tissue ReGeneratIon of Deep Partial-Thickness Burns: The LOGI Study",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kerecis Ltd.",
"sponsor_slug": "kerecis-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07376889",
"publication_url": "https://clinicaltrials.gov/study/NCT07376889",
"title": "COMBAT-SAB: Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Intermountain Health Care, Inc.",
"sponsor_slug": "intermountain-health-care-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284472",
"publication_url": "https://clinicaltrials.gov/study/NCT07284472",
"title": "Phase 2/3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Participants With Alzheimer's Disease Dementia",
"has_exemption": false,
"start_date": "2026-02-02",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Exciva GmbH",
"sponsor_slug": "exciva-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226284",
"publication_url": "https://clinicaltrials.gov/study/NCT07226284",
"title": "The Effects of Vagus Nerve Stimulation on Intrinsic Lower Leg Spinal Motoneuron Excitability in Parkinson's Disease.",
"has_exemption": false,
"start_date": "2026-02-10",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218315",
"publication_url": "https://clinicaltrials.gov/study/NCT07218315",
"title": "Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma",
"has_exemption": false,
"start_date": "2026-02-11",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07463599",
"publication_url": "https://clinicaltrials.gov/study/NCT07463599",
"title": "A Phase 1/2, Dose Escalation and Expansion Trial to Evaluate the Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma",
"has_exemption": false,
"start_date": "2026-02-17",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "HonorHealth Research Institute",
"sponsor_slug": "honorhealth-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07269041",
"publication_url": "https://clinicaltrials.gov/study/NCT07269041",
"title": "A Phase I Feasibility Study of HSPC Infusion Following Total Lymphoid Irradiation and Anti-thymocyte Globulin in Patients With a Pre-existing, Well-functioning HLA-matched Living-donor Liver Transplant to Induce Immune Tolerance.",
"has_exemption": false,
"start_date": "2026-02-20",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07306234",
"publication_url": "https://clinicaltrials.gov/study/NCT07306234",
"title": "Efficacy and Safety of Doxycycline Versus Macrolides for Mycoplasma Pneumoniae Infection in Children (DOMINO): A Protocol for a Multicenter, Randomized, Open-Label, Superiority Trial",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Young June Choe",
"sponsor_slug": "young-june-choe",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288489",
"publication_url": "https://clinicaltrials.gov/study/NCT07288489",
"title": "A Phase 3 Prospective Randomised Clinical Trial of VMX-C001 vs Usual Pharmacological Care in Patients Receiving a FXa Direct Oral Anticoagulant (FXa DOAC) Who Require Urgent Surgery or Other Invasive Procedure That is Associated With a High Risk of Bleeding, With or Without Planned Administration of Heparin (EQUILIBRIX-S)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VarmX B.V.",
"sponsor_slug": "varmx-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07461818",
"publication_url": "https://clinicaltrials.gov/study/NCT07461818",
"title": "POINT of CARE - Providing an Innovative New Triage and Treatment Strategy for Cervical Cancer Screening Efficiency",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Basic Health International, Inc.",
"sponsor_slug": "basic-health-international-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06422351",
"publication_url": "https://clinicaltrials.gov/study/NCT06422351",
"title": "A Phase 2 Clinical Trial to Evaluate the Efficacy of the Infusion of Autologous CD34+ Cells Transduced With a Lentiviral Vector Carrying the Codon Optimized Red Cell Pyruvate Kinase (coRPK) Gene in Subjects With Pyruvate Kinase Deficiency",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rocket Pharmaceuticals Inc.",
"sponsor_slug": "rocket-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07479615",
"publication_url": "https://clinicaltrials.gov/study/NCT07479615",
"title": "A Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Adult and Adolescent Patients With Moderate To-Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai Mabgeek Biotech.Co.Ltd",
"sponsor_slug": "shanghai-mabgeek-biotechcoltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07287098",
"publication_url": "https://clinicaltrials.gov/study/NCT07287098",
"title": "preEMBER: A Phase 2, Open-label Study Evaluating Imlunestrant in Premenopausal Women With Estrogen Receptor-Positive, HER2-Negative Breast Cancer",
"has_exemption": false,
"start_date": "2026-05-13",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07541287",
"publication_url": "https://clinicaltrials.gov/study/NCT07541287",
"title": "A Phase 2, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of JADE101 in Participants With Immunoglobulin A Nephropathy (JUNIPER)",
"has_exemption": false,
"start_date": "2026-05-19",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jade Biosciences, Inc.",
"sponsor_slug": "jade-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07124078",
"publication_url": "https://clinicaltrials.gov/study/NCT07124078",
"title": "A Phase 2, Randomized, Open-Label Study of Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)",
"has_exemption": false,
"start_date": "2026-05-20",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07311746",
"publication_url": "https://clinicaltrials.gov/study/NCT07311746",
"title": "Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07425054",
"publication_url": "https://clinicaltrials.gov/study/NCT07425054",
"title": "ctHPVDNA Adapted ChemoRadiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer (CHART-AC)",
"has_exemption": false,
"start_date": "2026-06-19",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jennifer Dorth",
"sponsor_slug": "jennifer-dorth",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07313852",
"publication_url": "https://clinicaltrials.gov/study/NCT07313852",
"title": "A Phase 1/2 Study of Concurrent Inotuzumab and Subcutaneous Blinatumomab in Adult Patients With B-cell Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07516847",
"publication_url": "https://clinicaltrials.gov/study/NCT07516847",
"title": "A Phase II, Prospective, Open-Label Study to Evaluate the Efficacy and Safety of Dapagliflozin for Anemia in Patients With Lower-Risk Myelodysplastic Syndromes",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Seug yun Yoon, MD",
"sponsor_slug": "seug-yun-yoon-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227909",
"publication_url": "https://clinicaltrials.gov/study/NCT07227909",
"title": "NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy",
"has_exemption": false,
"start_date": "2026-11-04",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05559801",
"publication_url": "https://clinicaltrials.gov/study/NCT05559801",
"title": "A Phase 1/2 Study to Examine the Safety and Preliminary Efficacy of Mesenchymal Stromal Cells on Linear Growth and Bone Health Parameters in Children With Type 3 Osteogenesis Imperfecta (OI)",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06716021",
"publication_url": "https://clinicaltrials.gov/study/NCT06716021",
"title": "Multi-Center, Placebo-Controlled, Phase 3 Study of Etripamil Nasal Spray (NS) in Patients With Atrial Fibrillation and Rapid Ventricular Rate (RVR)",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2029-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Milestone Pharmaceuticals Inc.",
"sponsor_slug": "milestone-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05064709",
"publication_url": "https://clinicaltrials.gov/study/NCT05064709",
"title": "Assessment of Implantable CCM in the Heart Failure Group With Higher Ejection Fraction",
"has_exemption": false,
"start_date": "2022-02-03",
"completion_date": "2029-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Impulse Dynamics",
"sponsor_slug": "impulse-dynamics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05053152",
"publication_url": "https://clinicaltrials.gov/study/NCT05053152",
"title": "A Phase II Double-Blinded, Placebo-Controlled Trial of PROstate OligoMETastatic RadiotHErapy With or Without ANdrogen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG Promethean)",
"has_exemption": false,
"start_date": "2022-04-20",
"completion_date": "2029-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06369259",
"publication_url": "https://clinicaltrials.gov/study/NCT06369259",
"title": "Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-02-24",
"completion_date": "2029-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07040280",
"publication_url": "https://clinicaltrials.gov/study/NCT07040280",
"title": "A Phase II Double-Blind Trial of Sulforaphane for Therapeutic Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2029-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Eastern Cooperative Oncology Group",
"sponsor_slug": "eastern-cooperative-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07058155",
"publication_url": "https://clinicaltrials.gov/study/NCT07058155",
"title": "OPTIMAL Trial: Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease",
"has_exemption": false,
"start_date": "2025-12-17",
"completion_date": "2029-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The Cleveland Clinic",
"sponsor_slug": "the-cleveland-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07276555",
"publication_url": "https://clinicaltrials.gov/study/NCT07276555",
"title": "Efficacy and Safety of Functional Neurogenesis Stimulation Therapy in Children With Autism Spectrum Disorder: A Multicenter, Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2029-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocytonix, Inc.",
"sponsor_slug": "neurocytonix-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07520318",
"publication_url": "https://clinicaltrials.gov/study/NCT07520318",
"title": "A Phase II/III Multicenter, Randomized, Masked, Active Comparator-Controlled Study to Evaluate the Safety and Efficacy of Two Doses of OCUL101, an Anti-VEGF and Anti-Complement C5, Bi-specific Humanized Antibody-Like \"Trap\" in Participants With Neovascular Age-Related Macular Degeneration With or Without Geographic Atrophy - STAT Study",
"has_exemption": false,
"start_date": "2026-04-17",
"completion_date": "2029-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shenzhen Oculgen Biomedical Technology Co., Ltd.",
"sponsor_slug": "shenzhen-oculgen-biomedical-technology-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07339059",
"publication_url": "https://clinicaltrials.gov/study/NCT07339059",
"title": "Phase II Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2029-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Bindu R Potugari",
"sponsor_slug": "bindu-r-potugari",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07527325",
"publication_url": "https://clinicaltrials.gov/study/NCT07527325",
"title": "Fianlimab and Cemiplimab as Total Neoadjuvant Therapy (TNT) For Melanoma",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Irvine",
"sponsor_slug": "university-of-california-irvine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07682454",
"publication_url": "https://clinicaltrials.gov/study/NCT07682454",
"title": "Utilizing Parenchymal Blood Volume Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2029-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07423104",
"publication_url": "https://clinicaltrials.gov/study/NCT07423104",
"title": "A Phase II Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory and Secondary Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2026-08-15",
"completion_date": "2029-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02911103",
"publication_url": "https://clinicaltrials.gov/study/NCT02911103",
"title": "Deep Brain Stimulation Surgery for Treatment of Focal Hand Dystonia",
"has_exemption": false,
"start_date": "2018-01-17",
"completion_date": "2029-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Neurological Disorders and Stroke (NINDS)",
"sponsor_slug": "national-institute-of-neurological-disorders-and-stroke-ninds",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07498517",
"publication_url": "https://clinicaltrials.gov/study/NCT07498517",
"title": "A Study to Evaluate the Safety and Efficacy of a Single Dose of Gruticibart for the Prevention of Early Catheter-related Thrombosis",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2029-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227610",
"publication_url": "https://clinicaltrials.gov/study/NCT07227610",
"title": "Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)",
"has_exemption": false,
"start_date": "2026-02-03",
"completion_date": "2029-02-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06508021",
"publication_url": "https://clinicaltrials.gov/study/NCT06508021",
"title": "A Phase 2/3, Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Two-Part Study With Open-Label Extension (OLE) to Assess the Efficacy and Safety of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)",
"has_exemption": false,
"start_date": "2024-10-25",
"completion_date": "2029-02-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Ashibio Inc",
"sponsor_slug": "ashibio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06935370",
"publication_url": "https://clinicaltrials.gov/study/NCT06935370",
"title": "EASi-HF Reduced - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Symptomatic Chronic Heart Failure (HF: NYHA II-IV) and Left Ventricular Ejection Fraction (LVEF) < 40%",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2029-02-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06351345",
"publication_url": "https://clinicaltrials.gov/study/NCT06351345",
"title": "129Xenon MR Imaging and Spectroscopy Response to Sotatercept in Pulmonary Arterial Hypertension",
"has_exemption": false,
"start_date": "2025-10-27",
"completion_date": "2029-02-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Bastiaan Driehuys",
"sponsor_slug": "bastiaan-driehuys",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07409181",
"publication_url": "https://clinicaltrials.gov/study/NCT07409181",
"title": "Randomised, Placebo-controlled, Double-blind, Parallel-group Phase II Study to Evaluate the Efficacy and Safety of Oral BI 3000202 in Patients With Moderate to Severe Systemic Lupus Erythematosus (SLE)",
"has_exemption": false,
"start_date": "2026-04-20",
"completion_date": "2029-02-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06692738",
"publication_url": "https://clinicaltrials.gov/study/NCT06692738",
"title": "A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab in Combination With Platinum-based Chemotherapy for the First-line Treatment of Patients With Metastatic Squamous Non-small Cell Lung Cancer Whose Tumors Express PD-L1 (ARTEMIDE-Lung02)",
"has_exemption": false,
"start_date": "2024-11-18",
"completion_date": "2029-02-05",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07608354",
"publication_url": "https://clinicaltrials.gov/study/NCT07608354",
"title": "A Phase IIb, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo in Adult Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)",
"has_exemption": false,
"start_date": "2026-06-11",
"completion_date": "2029-02-06",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07631637",
"publication_url": "https://clinicaltrials.gov/study/NCT07631637",
"title": "A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)",
"has_exemption": false,
"start_date": "2026-07-15",
"completion_date": "2029-02-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07124117",
"publication_url": "https://clinicaltrials.gov/study/NCT07124117",
"title": "A Phase 1/2, Open-Label, Dose-Escalation and Cohort-Expansion Study Evaluating the Safety, Pharmacokinetics, and Therapeutic Activity of OBI-902 in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2029-02-08",
"has_results": false,
"results_due": false,
"sponsor_name": "OBI Pharma, Inc",
"sponsor_slug": "obi-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06745323",
"publication_url": "https://clinicaltrials.gov/study/NCT06745323",
"title": "A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With Small Cell Lung Cancer (SCLC) (DeLLphi-309)",
"has_exemption": false,
"start_date": "2025-02-26",
"completion_date": "2029-02-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07416565",
"publication_url": "https://clinicaltrials.gov/study/NCT07416565",
"title": "A Prospective, Single-center Study of the Utility of the ATEC IOA Imaging Platform Tool in Intraoperative Imaging for Patients Undergoing Adult Spinal Deformity Surgery.",
"has_exemption": false,
"start_date": "2026-02-09",
"completion_date": "2029-02-09",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07611110",
"publication_url": "https://clinicaltrials.gov/study/NCT07611110",
"title": "A Phase III, Multicentre, Randomised Controlled Study to Evaluate the Efficacy and Safety of AZD2265 (FPI-2265) ²²⁵Ac-PSMA-I&T Compared With Standard of Care in Patients With PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)",
"has_exemption": false,
"start_date": "2026-05-04",
"completion_date": "2029-02-13",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04923893",
"publication_url": "https://clinicaltrials.gov/study/NCT04923893",
"title": "A Phase 3 Randomized Study Comparing Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Ciltacabtagene Autoleucel, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA Versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy",
"has_exemption": false,
"start_date": "2021-08-19",
"completion_date": "2029-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07693777",
"publication_url": "https://clinicaltrials.gov/study/NCT07693777",
"title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy and Safety of DR10624 in Subjects With Severe Hypertriglyceridemia Receiving Stable Lipid-Modifying Therapy",
"has_exemption": false,
"start_date": "2026-08-17",
"completion_date": "2029-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Zhejiang Doer Biologics Co., Ltd.",
"sponsor_slug": "zhejiang-doer-biologics-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07155226",
"publication_url": "https://clinicaltrials.gov/study/NCT07155226",
"title": "A Modular Phase I/II, Open-label, Multi-Centre Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression",
"has_exemption": false,
"start_date": "2026-01-09",
"completion_date": "2029-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06205602",
"publication_url": "https://clinicaltrials.gov/study/NCT06205602",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study of the Combination of Two Long-Acting Broadly Neutralizing Antibodies at ART Initiation in Adults Living With HIV-1 in Sub-Saharan Africa: The ACACIA Study",
"has_exemption": false,
"start_date": "2025-01-17",
"completion_date": "2029-02-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections",
"sponsor_slug": "advancing-clinical-therapeutics-globally-for-hivaids-and-other-infections",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07648264",
"publication_url": "https://clinicaltrials.gov/study/NCT07648264",
"title": "A Phase 3, Prospective, Open-label, Multicenter, Single-arm Study to Investigate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Subjects With Secondary Immune Deficiency Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies",
"has_exemption": false,
"start_date": "2026-07-25",
"completion_date": "2029-02-16",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06794541",
"publication_url": "https://clinicaltrials.gov/study/NCT06794541",
"title": "Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Intravenous Eravacycline in Pediatric Patients From 8 Years to Less Than 18 Years of Age With Complicated Intra-abdominal Infections (cIAI)",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2029-02-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Tetraphase Pharmaceuticals, Inc.",
"sponsor_slug": "tetraphase-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05314023",
"publication_url": "https://clinicaltrials.gov/study/NCT05314023",
"title": "A Phase 3 Open-Label Immunogenicity and Safety Study of 2-Dose Regimens of V503, a 9-Valent Human Papillomavirus (HPV) Vaccine in Chinese Males 9 Through 14 Years Old and 3-Dose Regimen of V503 in Chinese Males 9 Through 19 Years Old",
"has_exemption": false,
"start_date": "2022-05-07",
"completion_date": "2029-02-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06345729",
"publication_url": "https://clinicaltrials.gov/study/NCT06345729",
"title": "A Phase 3, Randomized, Double-blind, Multicenter Study of MK-1084 in Combination With Pembrolizumab Compared With Pembrolizumab Plus Placebo as Firstline Treatment of Participants With KRAS G12C-Mutant, Locally Advanced or Metastatic NSCLC With PD-L1 TPS ≥50% (KANDLELIT-004)",
"has_exemption": false,
"start_date": "2024-05-24",
"completion_date": "2029-02-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07684664",
"publication_url": "https://clinicaltrials.gov/study/NCT07684664",
"title": "A Single-Arm, Multi-Center, US-based Study to Obtain Data Regarding the Safety and Effectiveness of the Allurion Gastric Balloon System in the Post-Market Setting",
"has_exemption": false,
"start_date": "2026-07-15",
"completion_date": "2029-02-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Allurion Technologies",
"sponsor_slug": "allurion-technologies",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06290193",
"publication_url": "https://clinicaltrials.gov/study/NCT06290193",
"title": "A Prospective Randomized Trial of Acute Normovolemic Hemodilution (ANH) in Patients Undergoing Cytoreductive Surgery for Ovarian Cancer",
"has_exemption": false,
"start_date": "2024-02-23",
"completion_date": "2029-02-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06996782",
"publication_url": "https://clinicaltrials.gov/study/NCT06996782",
"title": "A Phase Ib/II Open-Label, Multicentre Platform Study Evaluating Novel Combinations in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-11-24",
"completion_date": "2029-02-23",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05562830",
"publication_url": "https://clinicaltrials.gov/study/NCT05562830",
"title": "A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Study of Investigational Agents With or Without Pembrolizumab in Participants With PD-1/L1 Refractory Locally Advanced or Metastatic Urothelial Carcinoma (KEYMAKER-U04): Substudy 04A",
"has_exemption": false,
"start_date": "2022-11-16",
"completion_date": "2029-02-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05744921",
"publication_url": "https://clinicaltrials.gov/study/NCT05744921",
"title": "An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria",
"has_exemption": false,
"start_date": "2023-03-07",
"completion_date": "2029-02-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05788536",
"publication_url": "https://clinicaltrials.gov/study/NCT05788536",
"title": "A Phase 1/2, Open-Label, Multicenter Trial With a Single Ascending Dose Cohort With Unilateral Intracochlear Injection Followed by a Bilateral Injection Expansion Cohort to Evaluate the Safety, Tolerability, and Efficacy of DB-OTO in Children and Infants With Biallelic hOTOF Mutations",
"has_exemption": false,
"start_date": "2023-06-27",
"completion_date": "2029-02-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06797999",
"publication_url": "https://clinicaltrials.gov/study/NCT06797999",
"title": "A First-in-human, Phase 1/2, Multicenter, Open-label, Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of ADCE-D01, a Humanized Anti-human uPARAP Antibody Linked to a Topoisomerase I Inhibitor, in Patients With Metastatic and/or Unresectable Soft Tissue Sarcoma",
"has_exemption": false,
"start_date": "2025-06-05",
"completion_date": "2029-02-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Adcendo ApS",
"sponsor_slug": "adcendo-aps",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222566",
"publication_url": "https://clinicaltrials.gov/study/NCT07222566",
"title": "AN INTERVENTIONAL PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER",
"has_exemption": false,
"start_date": "2026-01-06",
"completion_date": "2029-02-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02577120",
"publication_url": "https://clinicaltrials.gov/study/NCT02577120",
"title": "Wound Healing Endpoint and Recurrence",
"has_exemption": false,
"start_date": "2019-01-08",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Sashwati Roy",
"sponsor_slug": "sashwati-roy",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03495427",
"publication_url": "https://clinicaltrials.gov/study/NCT03495427",
"title": "The Utility of PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men With High GC Decipher® Test Scores: A Sub-aim of the VANDAAM Study (MCC #18523)",
"has_exemption": false,
"start_date": "2019-12-18",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04416984",
"publication_url": "https://clinicaltrials.gov/study/NCT04416984",
"title": "A Single-Arm, Open-Label, Phase 1/2 Study Evaluating the Safety, Efficacy, and Cellular Kinetics/Pharmacodynamics of ALLO-501A, an Anti-CD19 Allogeneic CAR T Cell Therapy, and ALLO-647, an Anti-CD52 Monoclonal Antibody, in Subjects With Relapsed/Refractory Large B-Cell Lymphoma (LBCL)",
"has_exemption": false,
"start_date": "2020-05-21",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Allogene Therapeutics",
"sponsor_slug": "allogene-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04469530",
"publication_url": "https://clinicaltrials.gov/study/NCT04469530",
"title": "A Maintenance Protocol of Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors",
"has_exemption": false,
"start_date": "2020-09-16",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05013333",
"publication_url": "https://clinicaltrials.gov/study/NCT05013333",
"title": "Post-Approval Study for AED 3 With Uni-padz",
"has_exemption": false,
"start_date": "2021-03-30",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Zoll Medical Corporation",
"sponsor_slug": "zoll-medical-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04783181",
"publication_url": "https://clinicaltrials.gov/study/NCT04783181",
"title": "A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation Study of the Safety and Efficacy of Gene Therapy for Congenital Adrenal Hyperplasia Through Administration of an Adeno-Associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human CYP21A2 Gene",
"has_exemption": false,
"start_date": "2021-07-01",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Adrenas Therapeutics Inc",
"sponsor_slug": "adrenas-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05135091",
"publication_url": "https://clinicaltrials.gov/study/NCT05135091",
"title": "A Study of Inhibitory Interneurons (NRTX-1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)",
"has_exemption": false,
"start_date": "2022-06-16",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurona Therapeutics",
"sponsor_slug": "neurona-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05541822",
"publication_url": "https://clinicaltrials.gov/study/NCT05541822",
"title": "A Phase 2 Multicenter, Open-Label, Parallel Cohort Expansion Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-Mesenchymal-epithelial Transition Factor (c-MET) Dysregulation",
"has_exemption": false,
"start_date": "2023-01-17",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Abion Inc",
"sponsor_slug": "abion-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05195905",
"publication_url": "https://clinicaltrials.gov/study/NCT05195905",
"title": "Evaluation of Spinal Cord Ischemia and Mortality and Morbidity After Endovascular Repair of Pararenal and Thoracoabdominal Aortic Aneurysm Using Surgeon-Modified Endografts",
"has_exemption": false,
"start_date": "2023-06-06",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Konstantinos Dean Arnaoutakis, MD",
"sponsor_slug": "konstantinos-dean-arnaoutakis-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05930561",
"publication_url": "https://clinicaltrials.gov/study/NCT05930561",
"title": "A Phase 2 Randomized, Active-Controlled, Double-masked Trial of Intravitreal 4D-150 Gene Therapy in Adults With Diabetic Macular Edema (SPECTRA)",
"has_exemption": false,
"start_date": "2023-08-09",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "4D Molecular Therapeutics",
"sponsor_slug": "4d-molecular-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06118905",
"publication_url": "https://clinicaltrials.gov/study/NCT06118905",
"title": "Preserving Geriatric Muscle With an Osteoporosis Medication",
"has_exemption": false,
"start_date": "2024-02-08",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Susan L. Greenspan",
"sponsor_slug": "susan-l-greenspan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06318169",
"publication_url": "https://clinicaltrials.gov/study/NCT06318169",
"title": "A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "89bio, Inc.",
"sponsor_slug": "89bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06295744",
"publication_url": "https://clinicaltrials.gov/study/NCT06295744",
"title": "Patient-Reported Outcomes and Cosmesis Following Five Fraction Whole Breast Irradiation With Simultaneous Integrated Boost",
"has_exemption": false,
"start_date": "2024-04-17",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06383390",
"publication_url": "https://clinicaltrials.gov/study/NCT06383390",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and Major Adverse Kidney Events in Participants With Body Mass Index ≥27 kg/m2 and Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease",
"has_exemption": false,
"start_date": "2024-04-30",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06177964",
"publication_url": "https://clinicaltrials.gov/study/NCT06177964",
"title": "Randomized Phase 2 Clinical Trial of Repeated Intratumoral and Cervical Perilymphatic Lerapolturev Injections Versus Lomustine in Recurrent Glioblastoma (GBM)",
"has_exemption": false,
"start_date": "2024-07-15",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Darell Bigner",
"sponsor_slug": "darell-bigner",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06415344",
"publication_url": "https://clinicaltrials.gov/study/NCT06415344",
"title": "A Long-term Extension Trial Investigating the Safety and Efficacy of GTX-102 in Patients With Angelman Syndrome",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Ultragenyx Pharmaceutical Inc",
"sponsor_slug": "ultragenyx-pharmaceutical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05665738",
"publication_url": "https://clinicaltrials.gov/study/NCT05665738",
"title": "Two-fraction High Dose Rate Brachytherapy as Monotherapy Delivered Three Hours Apart in Localized Prostate Cancer: A Pilot Study",
"has_exemption": false,
"start_date": "2024-09-11",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06347796",
"publication_url": "https://clinicaltrials.gov/study/NCT06347796",
"title": "Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Medical Branch, Galveston",
"sponsor_slug": "the-university-of-texas-medical-branch-galveston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05945329",
"publication_url": "https://clinicaltrials.gov/study/NCT05945329",
"title": "A Prospective, Randomized, Controlled, Multi-Center Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "C. R. Bard",
"sponsor_slug": "c-r-bard",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06712316",
"publication_url": "https://clinicaltrials.gov/study/NCT06712316",
"title": "A Phase II/III, Multisite, Randomized Master Protocol for a Global Trial of BNT327 in Combination With Chemotherapy and Other Investigational Agents in First-line Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-01-07",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06704152",
"publication_url": "https://clinicaltrials.gov/study/NCT06704152",
"title": "A Phase 1/2a Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS",
"has_exemption": false,
"start_date": "2025-02-04",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "BlueSphere Bio, Inc",
"sponsor_slug": "bluesphere-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06703125",
"publication_url": "https://clinicaltrials.gov/study/NCT06703125",
"title": "The Alama Project: Autism Outcomes and Neurobehavioral Markers in Young Children Born to Mothers With HIV in Kenya",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06777446",
"publication_url": "https://clinicaltrials.gov/study/NCT06777446",
"title": "Elective Adhesiolysis vs. a Wait-and-see Policy to Prevent Recurrences After Conservative Treatment of Adhesive Small Bowel Obstruction",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Radboud University Medical Center",
"sponsor_slug": "radboud-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06628453",
"publication_url": "https://clinicaltrials.gov/study/NCT06628453",
"title": "Continuous Glucose Monitoring for Management of Type 2 Diabetes in Pregnancy",
"has_exemption": false,
"start_date": "2025-04-08",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06777901",
"publication_url": "https://clinicaltrials.gov/study/NCT06777901",
"title": "Randomized Controlled Trial of the Auryon Atherectomy System Used in Combination With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone Treating Infrapopliteal Lesions in Subjects With Critical Limb Ischemia",
"has_exemption": false,
"start_date": "2025-04-21",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Angiodynamics, Inc.",
"sponsor_slug": "angiodynamics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06790966",
"publication_url": "https://clinicaltrials.gov/study/NCT06790966",
"title": "A Phase 3 Open-Label, Randomized Study of PDS0101 and Pembrolizumab vs Pembrolizumab Alone in First-Line Treatment of Unresectable Recurrent and/or Metastatic HPV16+ Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-05-30",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "PDS Biotechnology Corp.",
"sponsor_slug": "pds-biotechnology-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06844214",
"publication_url": "https://clinicaltrials.gov/study/NCT06844214",
"title": "A Phase 1/Phase 2 Open-label Single Arm Study With Dose Escalation (Part A), and Dose Expansion (Part B) Parts to Evaluate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants 10 to 55 Years Old With Non-congenital Myotonic Dystrophy Type 1",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06624644",
"publication_url": "https://clinicaltrials.gov/study/NCT06624644",
"title": "A Multicenter, Open-Label, Randomized, Controlled Study to Assess the Antitumor Activity of LNS8801 With and Without Pembrolizumab in Patients With Treatment-Refractory, Unresectable Melanoma",
"has_exemption": false,
"start_date": "2025-08-06",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Linnaeus Therapeutics, Inc.",
"sponsor_slug": "linnaeus-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07095465",
"publication_url": "https://clinicaltrials.gov/study/NCT07095465",
"title": "52-Week, Phase 3, Open-Label Extension Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)",
"has_exemption": false,
"start_date": "2025-11-14",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "ACADIA Pharmaceuticals Inc.",
"sponsor_slug": "acadia-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222488",
"publication_url": "https://clinicaltrials.gov/study/NCT07222488",
"title": "Phase 1/2 Study of Intravesical MK-3120 in BCG-Naïve or BCG-Exposed High-Risk Non-muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2025-12-09",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06796062",
"publication_url": "https://clinicaltrials.gov/study/NCT06796062",
"title": "A Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone Treatment",
"has_exemption": false,
"start_date": "2025-12-17",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07185997",
"publication_url": "https://clinicaltrials.gov/study/NCT07185997",
"title": "A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer With Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)",
"has_exemption": false,
"start_date": "2025-12-17",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "ArriVent BioPharma, Inc.",
"sponsor_slug": "arrivent-biopharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07130786",
"publication_url": "https://clinicaltrials.gov/study/NCT07130786",
"title": "A Phase II Randomized Open-Label Trial of Levetiracetam for Prevention of Seizures in Patients With Brain Metastases in Primary Motor Cortex",
"has_exemption": false,
"start_date": "2025-12-23",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Ayal A. Aizer, MD",
"sponsor_slug": "ayal-a-aizer-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06795074",
"publication_url": "https://clinicaltrials.gov/study/NCT06795074",
"title": "Risk of Recurrent Urethral Stricture After Treatment With Paclitaxel-Coated Dilatation Balloon (Optilume) Compared With Non-coated Dilatation Balloon - a Prospective Randomised Multicentre Study",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Vastra Gotaland Region",
"sponsor_slug": "vastra-gotaland-region",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07157514",
"publication_url": "https://clinicaltrials.gov/study/NCT07157514",
"title": "An Adaptive, Operationally Seamless Phase II / III Study of 131I-apamistamab-Led Allogeneic Hematopoietic Stem Cell Transplant in Patients With Relapsed or Refractory Acute Myeloid Leukemia With Active Disease",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Actinium Pharmaceuticals",
"sponsor_slug": "actinium-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07400029",
"publication_url": "https://clinicaltrials.gov/study/NCT07400029",
"title": "A Phase II Trial of Obecabtagene Autoleucel Consolidation in Adult Patients With Acute Lymphoblastic Leukemia in First Complete Remission Without Measurable Residual Disease",
"has_exemption": false,
"start_date": "2026-02-03",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07149363",
"publication_url": "https://clinicaltrials.gov/study/NCT07149363",
"title": "Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-02-12",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance Foundation Trials, LLC.",
"sponsor_slug": "alliance-foundation-trials-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07335497",
"publication_url": "https://clinicaltrials.gov/study/NCT07335497",
"title": "A Phase 1/2, Multicenter, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2026-02-17",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Crescent Biopharma, Inc.",
"sponsor_slug": "crescent-biopharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285668",
"publication_url": "https://clinicaltrials.gov/study/NCT07285668",
"title": "Phase I Study of Prophylactic TCRαβ+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies",
"has_exemption": false,
"start_date": "2026-02-26",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06225050",
"publication_url": "https://clinicaltrials.gov/study/NCT06225050",
"title": "A Single-center Pilot Study Using TCRα/β and CD45RA Depleted Stem Cell Grafts From Haploidentical Donors for Hematopoietic Cell Transplantation in Adults(HAPLO2022)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Miltenyi Biomedicine GmbH",
"sponsor_slug": "miltenyi-biomedicine-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07450430",
"publication_url": "https://clinicaltrials.gov/study/NCT07450430",
"title": "Double-blind, Randomized, Placebo Controlled Study to Evaluate Optimal Timing of Ketamine Initiation",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Children’s Hospital",
"sponsor_slug": "boston-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07042295",
"publication_url": "https://clinicaltrials.gov/study/NCT07042295",
"title": "A Randomized Phase II Study of Amivantamab (JNJ-61186372) and Hyaluronidase (rHuPH20) Versus Cetuximab in Immunocompromised Participants With Recurrent Inoperable or Metastatic Cutaneous Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-03-23",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07504055",
"publication_url": "https://clinicaltrials.gov/study/NCT07504055",
"title": "Effectiveness of Transcutaneous Spinal Cord Stimulation on Blood Pressure Regulation in Individuals With Chronic Spinal Cord Injury",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07043608",
"publication_url": "https://clinicaltrials.gov/study/NCT07043608",
"title": "A Phase II Study of Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases in Patients Previously Treated With Immune Checkpoint Inhibitors",
"has_exemption": false,
"start_date": "2026-05-30",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Kelly Fitzgerald, MD",
"sponsor_slug": "kelly-fitzgerald-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07647328",
"publication_url": "https://clinicaltrials.gov/study/NCT07647328",
"title": "SERAFA-1: A Single Arm, Open Label, Multicentre, Phase IIIb Study Of Camizestrant Plus Ribociclib in 1st Line Treatment of ER Positive, HER2-negative Advanced Breast Cancer Patients",
"has_exemption": false,
"start_date": "2026-06-15",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07685938",
"publication_url": "https://clinicaltrials.gov/study/NCT07685938",
"title": "Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07614360",
"publication_url": "https://clinicaltrials.gov/study/NCT07614360",
"title": "A Phase 2, Multicenter, Randomized, Open-label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Alternative and Approved Dosing Regimens of Belantamab Mafodotin in Combination With Bortezomib and Dexamethasone (BVd) in Participants With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-08-03",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07609719",
"publication_url": "https://clinicaltrials.gov/study/NCT07609719",
"title": "A Prospective, Multicenter, Single-arm Study of Ocrelizumab Administered Subcutaneously in Patients With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy",
"has_exemption": false,
"start_date": "2026-08-17",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07340658",
"publication_url": "https://clinicaltrials.gov/study/NCT07340658",
"title": "A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase III Study to Evaluate the Efficacy and Safety of Letrozole SIE Compared to Femara® (Both in Combination With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer (SIE-3)",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Rovi Pharmaceuticals Laboratories",
"sponsor_slug": "rovi-pharmaceuticals-laboratories",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07596485",
"publication_url": "https://clinicaltrials.gov/study/NCT07596485",
"title": "A Phase 1/2, Multicenter, Open-Label Study to Evaluate Safety, Tolerability, and PRELIminary EFficacy of Percutaneous Injection of RP-008 Followed by Daily Oral Varenicline in Patients With Trigeminal Neuralgia (The RELIEF Study)",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Kriya Therapeutics, Inc.",
"sponsor_slug": "kriya-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07693933",
"publication_url": "https://clinicaltrials.gov/study/NCT07693933",
"title": "Magnesium-Based Screws for Syndesmotic Fixation in Unstable Ankle Fractures",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07643519",
"publication_url": "https://clinicaltrials.gov/study/NCT07643519",
"title": "Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06783504",
"publication_url": "https://clinicaltrials.gov/study/NCT06783504",
"title": "Effect Of Percutaneous Electrical Nerve Field Stimulation (PENFS) On Symptom Control And Autonomic Nervous System Activity In Patients With Diabetes Mellitus",
"has_exemption": false,
"start_date": "2027-02-10",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03949855",
"publication_url": "https://clinicaltrials.gov/study/NCT03949855",
"title": "Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy (ITN080AI)",
"has_exemption": false,
"start_date": "2020-03-06",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05390892",
"publication_url": "https://clinicaltrials.gov/study/NCT05390892",
"title": "PRECIDENTD: PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes",
"has_exemption": false,
"start_date": "2022-09-26",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05432466",
"publication_url": "https://clinicaltrials.gov/study/NCT05432466",
"title": "A Phase 3 Randomized, Double-Blind, Decentralized Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in the Treatment of Patients With COL3A1-Positive Vascular Ehlers-Danlos Syndrome",
"has_exemption": false,
"start_date": "2022-11-07",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Acer Therapeutics Inc.",
"sponsor_slug": "acer-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072768",
"publication_url": "https://clinicaltrials.gov/study/NCT06072768",
"title": "Using SMART Design to Develop Dynamic Treatment Regimens for Glucocorticoid Tapering",
"has_exemption": false,
"start_date": "2023-03-09",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06014255",
"publication_url": "https://clinicaltrials.gov/study/NCT06014255",
"title": "A Phase 2 Randomized Trial of Neoadjuvant Enoblituzumab Versus Standard of Care in Men With High-Risk Localized Prostate Cancer: The Help Elucidate & Attack Longitudinally (HEAT) Prostate Cancer Randomized Study",
"has_exemption": false,
"start_date": "2024-02-16",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05896228",
"publication_url": "https://clinicaltrials.gov/study/NCT05896228",
"title": "Phase 2, Single-Arm Study of Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-02-20",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Benjamin T Diamond, MD",
"sponsor_slug": "benjamin-t-diamond-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05937854",
"publication_url": "https://clinicaltrials.gov/study/NCT05937854",
"title": "Effect of PDE5 Inhibitor on Respiratory Symptoms in COPD Complicated by Pulmonary Hypertension",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06412198",
"publication_url": "https://clinicaltrials.gov/study/NCT06412198",
"title": "A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06400121",
"publication_url": "https://clinicaltrials.gov/study/NCT06400121",
"title": "Phase 2, Randomized, Double-Blind, Placebo-Controlled, Single Intravenous Dose, Parallel Efficacy Study of Apimostinel With or Without Subsequent Automated Self-Association Training in Subjects With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2024-10-28",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Rebecca Price",
"sponsor_slug": "rebecca-price",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06972056",
"publication_url": "https://clinicaltrials.gov/study/NCT06972056",
"title": "A Comparative Effectiveness Study of Oral Medications Used for Migraine Prevention: The APT Comparison Study",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07038824",
"publication_url": "https://clinicaltrials.gov/study/NCT07038824",
"title": "A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping With an Initial Multiple Ascending Dose Part A to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ENTR-601-45, Followed by Part B to Evaluate the Safety and Efficacy of ENTR-601-45 (ELEVATE-45)",
"has_exemption": false,
"start_date": "2025-08-30",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Entrada Therapeutics, Inc.",
"sponsor_slug": "entrada-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07135895",
"publication_url": "https://clinicaltrials.gov/study/NCT07135895",
"title": "The Artix All-in-one Solution for Complete thrombEctomy With eNDovascular Approach",
"has_exemption": false,
"start_date": "2026-01-07",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Inari Medical",
"sponsor_slug": "inari-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187011",
"publication_url": "https://clinicaltrials.gov/study/NCT07187011",
"title": "Phase 2a Trial: Efficacy and Safety of PT150 in the Treatment of US Veterans With Posttraumatic Stress Disorder (PTSD)",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "San Diego Veterans Healthcare System",
"sponsor_slug": "san-diego-veterans-healthcare-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06941415",
"publication_url": "https://clinicaltrials.gov/study/NCT06941415",
"title": "Bumetanide vs. Furosemide for Adults Hospitalized With Cirrhosis: the BUFF Trial",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stacy Johnson",
"sponsor_slug": "stacy-johnson",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07016321",
"publication_url": "https://clinicaltrials.gov/study/NCT07016321",
"title": "Emetine for Viral Outbreaks: A Phase 2/3 Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Emetine for Dengue Fever (a.k.a. EVOLVE Antiviral Initiative)",
"has_exemption": false,
"start_date": "2026-06-25",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226713",
"publication_url": "https://clinicaltrials.gov/study/NCT07226713",
"title": "A Single-Arm, Open-label, Phase II Study Evaluating Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors - (POSTPONE)",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07670650",
"publication_url": "https://clinicaltrials.gov/study/NCT07670650",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of SAB-142 for Delaying the Progression of Type 1 Diabetes (T1D) in Patients With Stage 3 New Onset T1D, Recent Onset T1D, and Established T1D",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07686731",
"publication_url": "https://clinicaltrials.gov/study/NCT07686731",
"title": "Suvorexant: Targeting Orexin to Augment Exposure Therapy in Veterans With PTSD and Insomnia",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northern California Institute of Research and Education",
"sponsor_slug": "northern-california-institute-of-research-and-education",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06708455",
"publication_url": "https://clinicaltrials.gov/study/NCT06708455",
"title": "Phase 2 Trial of Autologous Rapamycin-Resistant Th1/Tc1 (RAPA-201) Cell Therapy of PD-(L)1 Resistant Malignant Melanoma",
"has_exemption": false,
"start_date": "2027-03-01",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Rapa Therapeutics LLC",
"sponsor_slug": "rapa-therapeutics-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07596901",
"publication_url": "https://clinicaltrials.gov/study/NCT07596901",
"title": "A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in Patients With Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2026-04-22",
"completion_date": "2029-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Aurinia Pharmaceuticals Inc.",
"sponsor_slug": "aurinia-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07611214",
"publication_url": "https://clinicaltrials.gov/study/NCT07611214",
"title": "PRESERVE: A Multi-Center Phase 4 Study of the Efficacy and Safety of LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab at Inducing Rapid Renal Response in Patients With Lupus Nephritis",
"has_exemption": false,
"start_date": "2026-04-22",
"completion_date": "2029-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Aurinia Pharmaceuticals Inc.",
"sponsor_slug": "aurinia-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07501702",
"publication_url": "https://clinicaltrials.gov/study/NCT07501702",
"title": "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a Long-term Extension of Povetacicept in Adults With Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2026-05-13",
"completion_date": "2029-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07652294",
"publication_url": "https://clinicaltrials.gov/study/NCT07652294",
"title": "A Study to Evaluate the Long-term Safety and Efficacy of Long-acting Antibodies as Single Agents and in Combinations in Participants With Inflammatory Bowel Disease",
"has_exemption": false,
"start_date": "2026-06-08",
"completion_date": "2029-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Spyre Therapeutics, Inc.",
"sponsor_slug": "spyre-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07686263",
"publication_url": "https://clinicaltrials.gov/study/NCT07686263",
"title": "A Phase 3 Double-blind, Placebo-controlled Randomized Withdrawal Maintenance Trial of KarXT Treatment in Participants With Schizophrenia",
"has_exemption": false,
"start_date": "2026-09-03",
"completion_date": "2029-03-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Karuna Therapeutics, Inc., a Bristol Myers Squibb company",
"sponsor_slug": "karuna-therapeutics-inc-a-bristol-myers-squibb-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07042919",
"publication_url": "https://clinicaltrials.gov/study/NCT07042919",
"title": "A Phase Ib/II Study of Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2026-03-30",
"completion_date": "2029-03-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Devalingam Mahalingam",
"sponsor_slug": "devalingam-mahalingam",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06112418",
"publication_url": "https://clinicaltrials.gov/study/NCT06112418",
"title": "A Randomized Comparison of Cleerly Coronary Artery Disease Stage-Based Care Versus Risk Factor-Based Care for Primary Prevention of Cardiovascular Events",
"has_exemption": false,
"start_date": "2024-03-06",
"completion_date": "2029-03-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Cleerly, Inc.",
"sponsor_slug": "cleerly-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227298",
"publication_url": "https://clinicaltrials.gov/study/NCT07227298",
"title": "AN INTERVENTIONAL OPEN-LABEL PHASE 1B/2 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND PRELIMINARY EFFICACY OF PF-08634404 IN COMBINATION WITH DIFFERENT ANTICANCER AGENTS IN PARTICIPANTS WITH ADVANCED SOLID TUMORS",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2029-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05142696",
"publication_url": "https://clinicaltrials.gov/study/NCT05142696",
"title": "A Phase Ib/II Dose Finding Study Assessing Safety and Efficacy of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Extensive Stage Small Cell Lung Cancer (ES-SCLC) in Combination With Carboplatin, Etoposide, and Atezolizumab in Induction and With Atezolizumab in Maintenance Phase",
"has_exemption": false,
"start_date": "2022-07-13",
"completion_date": "2029-03-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06665256",
"publication_url": "https://clinicaltrials.gov/study/NCT06665256",
"title": "A Phase 2, Randomized, Open-label, Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Comparator in Participants With Severe Refractory Idiopathic Inflammatory Myopathies (IIM)",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-03-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05174169",
"publication_url": "https://clinicaltrials.gov/study/NCT05174169",
"title": "Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease",
"has_exemption": false,
"start_date": "2022-07-08",
"completion_date": "2029-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06883305",
"publication_url": "https://clinicaltrials.gov/study/NCT06883305",
"title": "A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2029-03-13",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06878261",
"publication_url": "https://clinicaltrials.gov/study/NCT06878261",
"title": "A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease",
"has_exemption": false,
"start_date": "2025-03-25",
"completion_date": "2029-03-13",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06637423",
"publication_url": "https://clinicaltrials.gov/study/NCT06637423",
"title": "A Phase 1/2 Open-label Clinical Study to Evaluate the Safety and Efficacy of Intravesical Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in Participants With Intermediate-risk Non-muscle Invasive Bladder Cancer (NMIBC)",
"has_exemption": false,
"start_date": "2024-12-20",
"completion_date": "2029-03-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05827016",
"publication_url": "https://clinicaltrials.gov/study/NCT05827016",
"title": "A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy After Autologous Stem Cell Transplantation (ASCT) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) (EXCALIBER-Maintenance)",
"has_exemption": false,
"start_date": "2023-06-22",
"completion_date": "2029-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04305691",
"publication_url": "https://clinicaltrials.gov/study/NCT04305691",
"title": "A Phase 2 Trial of Ixazomib for Kaposi Sarcoma",
"has_exemption": false,
"start_date": "2023-11-07",
"completion_date": "2029-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "AIDS Malignancy Consortium",
"sponsor_slug": "aids-malignancy-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225361",
"publication_url": "https://clinicaltrials.gov/study/NCT07225361",
"title": "Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-11-28",
"completion_date": "2029-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07584707",
"publication_url": "https://clinicaltrials.gov/study/NCT07584707",
"title": "Investigation of Motorized Lower-limb Prostheses",
"has_exemption": false,
"start_date": "2026-04-16",
"completion_date": "2029-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Northern Arizona University",
"sponsor_slug": "northern-arizona-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07520110",
"publication_url": "https://clinicaltrials.gov/study/NCT07520110",
"title": "Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis (MAVRIC)",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2029-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Massachusetts, Worcester",
"sponsor_slug": "university-of-massachusetts-worcester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07681713",
"publication_url": "https://clinicaltrials.gov/study/NCT07681713",
"title": "Evaluation of Long-Term Efficacy of Vatiquinone for the Treatment of Friedreich's Ataxia",
"has_exemption": false,
"start_date": "2026-08-15",
"completion_date": "2029-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "PTC Therapeutics",
"sponsor_slug": "ptc-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06921785",
"publication_url": "https://clinicaltrials.gov/study/NCT06921785",
"title": "A Phase III, Randomised, Open-label, Sponsor-blinded, Multicentre Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2025-05-06",
"completion_date": "2029-03-16",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07238400",
"publication_url": "https://clinicaltrials.gov/study/NCT07238400",
"title": "Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia",
"has_exemption": false,
"start_date": "2026-03-20",
"completion_date": "2029-03-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06495125",
"publication_url": "https://clinicaltrials.gov/study/NCT06495125",
"title": "A Phase 2 Study of Defactinib and Avutometinib, in Combination With Nivolumab for Patients With Anti-PD1 Refractory LKB1-Mutant Advanced Lung Adenocarcinoma",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2029-03-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05855200",
"publication_url": "https://clinicaltrials.gov/study/NCT05855200",
"title": "A Phase 3, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy Versus Standard of Care in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer",
"has_exemption": false,
"start_date": "2023-08-01",
"completion_date": "2029-03-19",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07671001",
"publication_url": "https://clinicaltrials.gov/study/NCT07671001",
"title": "A Phase 3, Open-label Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Depemokimab (GSK3511294) Administered Subcutaneously as Add on Maintenance Treatment of Asthma With Type 2 Inflammation Characterised by an Eosinophilic Phenotype in Participants Aged 6 to 11 Years Old",
"has_exemption": false,
"start_date": "2026-06-26",
"completion_date": "2029-03-19",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06787950",
"publication_url": "https://clinicaltrials.gov/study/NCT06787950",
"title": "A Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Anti-tumor Activity of ASN-3186 in Patients with Advanced Solid Tumors.",
"has_exemption": false,
"start_date": "2025-02-20",
"completion_date": "2029-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Jiangsu Yahong Meditech Co., Ltd aka Asieris",
"sponsor_slug": "jiangsu-yahong-meditech-co-ltd-aka-asieris",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07266831",
"publication_url": "https://clinicaltrials.gov/study/NCT07266831",
"title": "A Phase 2/3, Randomized, Active-Controlled, Open-Label (Phase 2) and Double-Blind (Phase 3) Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) Once Daily in Treatment-Naïve Adult Participants Living With HIV-1",
"has_exemption": false,
"start_date": "2025-12-18",
"completion_date": "2029-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07316010",
"publication_url": "https://clinicaltrials.gov/study/NCT07316010",
"title": "Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma",
"has_exemption": false,
"start_date": "2026-03-17",
"completion_date": "2029-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06439082",
"publication_url": "https://clinicaltrials.gov/study/NCT06439082",
"title": "A Phase III, Multicenter, Randomized, Placebo Controlled, Double-blind Study to Assess Efficacy and Safety of Crizanlizumab (5 mg/kg) Versus Placebo, With or Without Hydroxyurea/Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patients With Frequent Vaso-Occlusive Crises",
"has_exemption": false,
"start_date": "2024-10-24",
"completion_date": "2029-03-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}